1365803-27-5

Basic information

• Product Name: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-benzotriazole
• Synonyms: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-benzotriazole
• CAS NO: 1365803-27-5
• Molecular Weight: 487.409
• Mol File: 1365803-27-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-benzotriazole(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-benzotriazole(1365803-27-5)
• EPA Substance Registry System: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-benzotriazole(1365803-27-5)

Safety Data

• Hazardous Substances Data: 1365803-27-5(Hazardous Substances Data)

Upstream product

• 1257651-13-0 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,2,3]triazole 
• 76-83-5 trityl chloride 

Downstream Products

• 1365802-75-0 4-(1H-1,2,3-benzotriazol-6-yl)-N-[3,5-bis(trifluoromethyl)phenyl]phthalazin-1-amine 
• 1365803-28-6 N-[3,5-bis(trifluoromethyl)phenyl]-4-(1-trityl-1H-benzotriazol-6-yl)phthalazin-1-amine 

Relevant articles and documents

PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS

JAK1 inhibitors of structural formula (I), wherein Ar1, Ar2, Q, W, X, Y, and Z are defined in the specification, pharmaceutically acceptable salts thereof, compositions thereof, and use of the compounds and compositions for treating diseases. The invention also comprises use of the compounds in and for the manufacture of medicaments, particularly for treating diseases.